Masimo (NASDAQ:MASI) Rating Lowered to Hold at Wolfe Research

Masimo (NASDAQ:MASI) was downgraded by research analysts at Wolfe Research from a “strong-buy” rating to a “hold” rating in a research note issued on Thursday,Zacks.com reports.

A number of other equities analysts also recently issued reports on MASI. Bank of America assumed coverage on Masimo in a research note on Monday, November 17th. They set a “neutral” rating and a $162.00 price target for the company. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday. Stifel Nicolaus set a $180.00 price target on Masimo in a research report on Tuesday. Piper Sandler lowered shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price for the company. in a research note on Tuesday. Finally, Wells Fargo & Company downgraded shares of Masimo from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $190.00 to $180.00 in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $181.17.

Masimo Stock Performance

MASI opened at $175.33 on Thursday. The company has a market cap of $9.42 billion, a price-to-earnings ratio of -16.63, a PEG ratio of 1.78 and a beta of 1.26. The company’s fifty day moving average price is $138.40 and its two-hundred day moving average price is $143.06. Masimo has a 1-year low of $125.94 and a 1-year high of $194.88. The company has a current ratio of 2.84, a quick ratio of 1.92 and a debt-to-equity ratio of 0.69.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Global Retirement Partners LLC bought a new stake in shares of Masimo in the 4th quarter worth approximately $27,000. Aster Capital Management DIFC Ltd bought a new position in shares of Masimo during the 4th quarter worth $28,000. Los Angeles Capital Management LLC purchased a new stake in Masimo in the 4th quarter worth about $31,000. MAI Capital Management raised its stake in Masimo by 176.7% in the 2nd quarter. MAI Capital Management now owns 202 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 129 shares during the period. Finally, Rothschild Investment LLC lifted its holdings in Masimo by 12,950.0% during the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 259 shares during the last quarter. 85.96% of the stock is currently owned by hedge funds and other institutional investors.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.